Dubai Investments reports net profit of $55mln in Q1 2019
Total assets increased to $5.48bln
WAM (Emirates News Agency) - 05-May-2019
Globalpharma Co. (L.L.C)
Also known as: Globalpharma Last updated on: 10 September 2018
fast facts
Business SummaryManufacture of generic pharmaceuticals including tablets, capsules, dry syrup and liquid drugs.Country of IncorporationUAEOwnership TypeForeignEstablished In1998Primary SectorHealth CareNumber of Employees170Latest News
investment
Dubai Investments reports net profit in Q1 2019
Increase in gain on fair valuation of investments which is quite encouraging as it indicates improving market conditions
Press Release - 05-May-2019Industry experts address 150 healthcare professionals at Quality in Primary Care Globalpharma seminar
Around 150 healthcare professionals from the UAE, Saudi Arabia and Iraq attended the interactive seminar
Press Release - 16-Mar-2019Poland to promote Biotech and pharma sector in UAE
The Polish Investment and Trade Agency along with leading Polish companies will highlight the country's Bio-Pharma offerings at the upcoming Middle East Pharma Cold Chain Congress in Dubai
Press Release - 14-Mar-2019Dubai Investments takes 100% control of Globalpharma
Company buys back 66% stake that it divested five years ago to French pharma giant Sanofi
Thomson Reuters Projects News - 07-Feb-2019Contact details
Primary address
Globalpharma Co. (L.L.C) BuildingEmirates Road
Dubai Investment Park
72168
UAE
Dubai
Region
DubaiCONTACT
- Tel: +971 4-885-1222
- Tel: +971 4-809-0900
- Fax: +971 4-885-1223
- Email: info@globalpharma-sanofi.com
- www.globalpharma-sanofi.com
Find Out More Information
Have questions regarding this company profile? Get detailed company information on Thomson Reuters Business Development MENA.
Company information provided by © 2019 Thomson Reuters
Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).